Close
Call for proposals for feasibility studies has now closed
Feasibility Studies Funding
The deadline for the submission of applications for funding of up to £100,000 to support feasibility studies has now passed.
Funding will be awarded in September 2020.
Vax-Hub is pleased to announce the award of interaction vouchers to support the following collaborative activity.
| Partners | Project title |
|---|---|
| Hilleman Labs & UCL | Establishing the use of microscale chromatography-for downstream process optimization of Group B streptococcus polysaccharides |
| Phenotypeca Ltd and the University of Oxford | Exploiting the genetic diversity of Saccharomyces cerevisiae for VLP production |
| Sartorius Stedim Biotech and the University of Oxford | Cost of goods evaluation of adenovirus-based vaccine against Coronavirus |
| Sartorius Stedim Biotech and the University of Oxford | Improving scalability and productivity of an adenovirus-based vaccine against Coronavirus |
| Univercells, University of Leeds & UCL | Proof of principle synthesis of polio virus-like particles in an E. coli cell-free manufacturing platform |
| Vironova and UCL | MiniTEM analysis: characterisation of Viral Vaccines, Vectors and VLPs |
Vax-Hub membership
If you are not currently a member of the Hub but would be interested in joining in order to access platform funding opportunities and other benefits, please contact us: E: vaxhub@ucl.ac.uk